Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/06/2012 | US20120308676 Antiviral composition containing an aleurites fordii or daphne kiusiana extract or a fraction thereof as an active ingredient |
12/06/2012 | US20120308670 Topical Medicament for the Treatment of Psoriasis |
12/06/2012 | US20120308660 Nanocoatings for biological materials |
12/06/2012 | US20120308653 Wormwood pill containing 95% of wormwood ethyl alcohol extract that has inactivation efficacy of the h1n1 virus and the h9n2 avian influenza virus |
12/06/2012 | US20120308652 Oral form of administration comprising entecavir |
12/06/2012 | US20120308644 Compositions for mucosal delivery of agents |
12/06/2012 | US20120308642 Inhibiting hepatitis c viral replication with sirna combinations |
12/06/2012 | US20120308638 Antimicrobial peptides |
12/06/2012 | US20120308637 Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith |
12/06/2012 | US20120308633 Nanostructured material formulated with bone cement for effective antibiotic delivery |
12/06/2012 | US20120308627 Liquid-filled protein-phosphatidic acid capsule dispersions |
12/06/2012 | US20120308623 Composition comprising nanoparticles of ti02 |
12/06/2012 | US20120308618 Ic31 nanoparticles |
12/06/2012 | US20120308615 Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunization |
12/06/2012 | US20120308608 Interferon-inducing compounds and uses thereof |
12/06/2012 | US20120308607 Production and use of human cd124- and cd-116-positive tumor cell lines in the production of allogenic or semi-allogenic immunotherapy agents |
12/06/2012 | US20120308603 Dna vaccine against virus of yellow fever |
12/06/2012 | US20120308602 Recombinant RSV Virus Expression Systems And Vaccines |
12/06/2012 | US20120308600 Polysaccharide immunogens conjugated to e. coli carrier proteins |
12/06/2012 | US20120308597 Serologic correlates of protection against bacillis anthracis infection |
12/06/2012 | US20120308596 Novel streptococcus antigens |
12/06/2012 | US20120308595 Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease |
12/06/2012 | US20120308594 Hcv clade and prototype sequences thereof |
12/06/2012 | US20120308593 Immunological Compositions for HIV |
12/06/2012 | US20120308592 Immunogenic HPV L2-Containing VLPs and Related Compositions, Constructs, and Therapeutic Methods |
12/06/2012 | US20120308589 Sinomenine derivatives, synthetic methods and uses thereof |
12/06/2012 | US20120308586 Composition based on extra virgin olive oils |
12/06/2012 | US20120308581 Compositions and methods for detecting tlr3 |
12/06/2012 | US20120308580 Hepatitus b virus specific antibody and usese thereof |
12/06/2012 | US20120308579 Method of making and using a composition for delivering viral immunogen immunoglobulin inhibitor to the nasal pharyngeal membrane |
12/06/2012 | US20120308552 Hemostatic bio-material composition and method |
12/06/2012 | US20120308538 Preventing spoilage in alcohol fermentations |
12/06/2012 | US20120308535 Pharmaceutical Composition Containing Expanded Adult Stem Cells and Methods of Using Same for Treatment |
12/06/2012 | US20120308528 Methods and Compositions for Gene Inactivation |
12/06/2012 | US20120308527 Prevention of opportunistic infections in immune-comprised subjects |
12/06/2012 | US20120308525 Nutritional compositions including a high protein component and exogenous nucleotides |
12/06/2012 | US20120308520 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
12/06/2012 | US20120308519 Anti-Arenaviral Compounds |
12/06/2012 | US20120308517 Compositions for the treatment of infectious and tumoural diseases |
12/06/2012 | US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
12/06/2012 | CA2838023A1 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom |
12/06/2012 | CA2837759A1 Novel antibacterial combination therapy |
12/06/2012 | CA2837481A1 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections |
12/06/2012 | CA2837279A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain |
12/06/2012 | CA2837125A1 Combined vaccines for prevention of porcine virus infections |
12/06/2012 | CA2836511A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections |
12/06/2012 | CA2835272A1 Pharmaceutical antiretroviral composition |
12/05/2012 | EP2530075A2 Modulators of ATP-binding cassette transporters |
12/05/2012 | EP2529793A2 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
12/05/2012 | EP2529737A1 Antibacterial combination therapy |
12/05/2012 | EP2529733A1 Antibacterial combination therapy |
12/05/2012 | EP2529728A1 Pharmaceutical compositions for the treatment of bacterial infections |
12/05/2012 | EP2528939A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
12/05/2012 | EP2528926A1 Hepatitis c inhibitor compounds |
12/05/2012 | EP2528922A1 Polyheterocyclic compounds highly potent as hcv inhibitors |
12/05/2012 | EP2528904A1 Production and use of antibacterial, antiproliferative, and antiphytopathogenic benzanthracenes |
12/05/2012 | EP2528624A1 Extracellular ifi16 as therapeutic agents |
12/05/2012 | EP2528593A2 Effervescent formulations comprising cefprozil as active agent |
12/05/2012 | EP2528591A2 Effervescent formulations comprising cefaclor |
12/05/2012 | EP2528590A2 Effervescent dosage forms comprising cephalosporin antibiotic |
12/05/2012 | EP2528589A2 Stable efervescent formulations comprising cefaclor |
12/05/2012 | CN202568934U Tablet capsule filled with glipizide solid preparations and metformin solid preparations |
12/05/2012 | CN202568921U Vagina film special for women |
12/05/2012 | CN202566566U Handmade Chinese medicinal bamboo charcoal insole |
12/05/2012 | CN1976704B Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
12/05/2012 | CN1437479B Recombinant intracellular pathogen vaccines and methods for use |
12/05/2012 | CN102812023A Anti - infective pyrido (1,2 -a) pyrimidines |
12/05/2012 | CN102812007A Therapeutic agent for hepatitis C |
12/05/2012 | CN102811998A New Inhibitors Of Cyclophilins And Uses Thereof |
12/05/2012 | CN102811733A Bacteremia-associated Antigen From Staphylococcus Aureus |
12/05/2012 | CN102811724A Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same |
12/05/2012 | CN102807989A Preparation method of recombination live vector vaccines for diseases of canid and/or feline |
12/05/2012 | CN102807972A Hepatitis A virus purification method |
12/05/2012 | CN102807621A Fusion protein containing diphtheria toxin non-toxic mutant cross-reacting material 197 (CRM197) or segment thereof |
12/05/2012 | CN102807617A Antibodies to M-CSF |
12/05/2012 | CN102807613A Secreted protein with chemotactic activity and medicament usage thereof |
12/05/2012 | CN102807610A Antibacterial peptides and application of antibacterial peptides to preparation of medicament resisting drug-resistant bacteria |
12/05/2012 | CN102807608A Peptide sequences and compositions |
12/05/2012 | CN102807607A Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound |
12/05/2012 | CN102807526A Preparation method and application of histone deacetylase inhibitor ZYJ-D08a and epimer thereof |
12/05/2012 | CN102805872A HBV-heat shock protein 70 fusion gene vaccine delivered by attenuated salmonella typhimurium, and preparation and application thereof |
12/05/2012 | CN102805868A Method of treatment using ligand-immunogen conjugates |
12/05/2012 | CN102805866A Pharmaceutic preparation for livestock and application thereof |
12/05/2012 | CN102805864A Newcastle disease and H9N2 subtype avian influenza bivalent inactivated vaccine and preparation method thereof |
12/05/2012 | CN102805863A Preparation method of novel bunyavirus purification inactivated vaccine by culturing human diploid cell |
12/05/2012 | CN102805862A Preparation method for SFTS bunyavirus purification and inactivation vaccines through VERO cell culture |
12/05/2012 | CN102805832A External medicament for treating dermatophytosis and preparation method thereof |
12/05/2012 | CN102805831A Medical disinfectant and preparing method thereof |
12/05/2012 | CN102805810A Chinese medicinal preparation for treating acquired immune deficiency syndrome (AIDS) and preparation method thereof |
12/05/2012 | CN102805809A Oral liquid for treating infant myocarditis |
12/05/2012 | CN102805793A Oral Chinese medicinal pill for treating osteomyelitis |
12/05/2012 | CN102805783A Decoction drug for treating impetigo |
12/05/2012 | CN102805776A Traditional Chinese medicine composition and preparation method of traditional Chinese medicine composition |
12/05/2012 | CN102805772A Application of coptis chinensis, amur cork-tree bark, Chinese rhubarb and skullcap dysentery inhibiting particles to preparation of medicines for treating intestinal diseases of poultry, and medicinal composition formed by compounding particles |
12/05/2012 | CN102805767A Heat stranguria removal granule raw material polygonum capitatum extract with anti-gonococcus effect |
12/05/2012 | CN102805763A Preparation method of plant-based slow-release compound antibacterial agent for prevention and control of skin ulcer syndrome of Apostichopus japonicus |
12/05/2012 | CN102805748A Pazufloxacin mesilate medicinal preparation and preparation method thereof |
12/05/2012 | CN102805747A Use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and pharmaceutically acceptable salt or derivative of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine in pharmacy |
12/05/2012 | CN102805731A Posaconazole dry suspension and preparation method thereof |
12/05/2012 | CN102805725A Azlocillin sodium medicinal composition for injection and preparation method for azlocillin sodium medicinal composition for injection |